Neural & Cognitive System
System Overview Neural Biology. Investigated at the Peptide Level.
The Neural & Cognitive System encompasses the molecular and cellular mechanisms through which the central nervous system maintains structural integrity, regulates neurotransmitter balance, and sustains cognitive function across the lifespan. Research in this domain has increasingly turned to endogenous neuropeptides — short amino acid sequences that act as signaling molecules throughout the brain and periphery — as tools for investigating the biological substrates of memory, attention, anxiety, neuroprotection, and circadian regulation. Unlike classical pharmacological agents that often target single receptors with binary activity, many neuropeptides exert pleiotropic effects across multiple neurotransmitter systems simultaneously, making them valuable research probes for understanding the integrated biology of neural function.
Core Mechanisms Four Research Axes in Neural & Cognitive System
Brain-derived neurotrophic factor (BDNF) and its high-affinity receptor TrkB are central regulators of neuronal survival, synaptic plasticity, and long-term potentiation — the cellular basis of memory consolidation. Research investigates how specific peptides modulate BDNF transcription and TrkB activation in hippocampal and cortical tissue, examining downstream effects on learning-related gene expression.
The GABAergic system is the brain's principal inhibitory neurotransmitter network, and its dysregulation is implicated in anxiety, mood disorders, and sleep disruption. Studies examine how neuropeptides modulate GABAA receptor subunit expression and binding kinetics — and how inhibition of enkephalin degradation contributes to multi-pathway anxiolytic profiles distinct from classical benzodiazepine mechanisms.
The pineal gland and its primary output — melatonin synthesis regulated by N-acetyltransferase activity — sit at the interface of light-dark entrainment, sleep architecture, and neuroendocrine timing. Research investigates how short peptide bioregulators influence circadian gene expression, pineal function, and slow-wave sleep biology through mechanisms that operate at the transcriptional rather than purely receptor-binding level.
Neuroprotection research investigates the molecular defenses that determine neuronal survival under conditions of oxygen deprivation, excitotoxicity, and oxidative stress. Studies examine antioxidant enzyme upregulation (SOD2, GPx1), caspase-3/p53 pathway modulation, and the hypothesis that short peptide bioregulators may influence gene expression through direct DNA interactions at promoter regions — an epigenetic mechanism distinct from classical pharmacology, and one that remains the subject of ongoing scientific investigation.
Related Compounds Research Compounds in This System
Synthetic heptapeptide analog of ACTH(4-10) with Pro-Gly-Pro C-terminal extension. Investigated for rapid BDNF/TrkB upregulation in hippocampal tissue, dopaminergic and serotonergic modulation, and neuroprotective activity in preclinical ischemia models. Registered in Russia for stroke and cognitive disorders. Peer-reviewed literature available on PubMed (Dolotov et al., 2006; PMID: 16996037).
View ProductPathways & Biological Context Key Research Pathways
- BDNF / TrkB – Core neurotrophic axis in synaptic plasticity, memory consolidation, and neuroprotection
- GABAA receptor / allosteric modulation – Principal inhibitory system; modulation of neuronal excitability and anxiolytic signaling
- Serotonin (5-HT) turnover / 5-HT2A – Mood, anxiety, and cognitive regulation via serotonergic neurotransmission
- Dopamine / DAT signaling – Attention, motivation, and reward circuit modulation
- Enkephalin degradation pathway – Endogenous opioid peptide regulation and anxiety modulation
- ACTH / melanocortin receptor axis – Molecular origin of the fragments investigated in Semax research
- Circadian clock genes (CLOCK, BMAL1, PER) – Transcriptional regulation of circadian rhythm
- Pineal N-acetyltransferase / melatonin – Melatonin synthesis and slow-wave sleep architecture
- SOD2 / GPx1 antioxidant expression – Oxidative stress response in central nervous system tissue
Related Articles - Research Library Explore the Science Behind This System
The Research Library provides in-depth editorial coverage of the mechanisms, evidence, and investigative directions relevant to this system. Each article connects to one or more related compounds in the AXION catalog.
All compounds listed in this system are classified as Research Use Only (RUO). They are not approved for therapeutic, diagnostic, or clinical use in humans or animals. AXION does not make therapeutic claims of any kind. Access to compounds is available through AXION's structured access model.